Psychedelic drugs for treatment of mental illness focus of U of C research chair
Jun 9, 2021 | 10:50 AM
-
Share on Facebook
-
Share on Twitter
- Copy Link
CALGARY – The University of Calgary has announced a new positio that will focus on research into the potential use of psychedelic drugs to improve mental health.
It’s believed to be the first of its kind in Canada.
A $3-million commitment for the Parker Psychedelic Research Chair came from Jim Parker, who says he saw his niece make great strides treating her post-traumatic stress disorder at a clinic in California.
He says she received five rounds of intravenous ketamine therapy, precisely dosed under medical supervision.
